Suchergebnisse
10
Alles
Conavi Medical Announces Uplisting to OTCQB Venture Market
06. März 2025 07:00 ET
|
Conavi Medical Corp.
- Expected to enhance visibility and access to U.S. investors - Trading to commence on March 6, 2025 TORONTO, March 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB:...
Conavi Medical Highly Encouraged by New U.S. Intracoronary Guidelines
04. März 2025 07:00 ET
|
Conavi Medical Corp.
– IVUS and OCT cited as playing essential and complementary roles, validating Novasight’s unique hybrid imaging capability – Guidelines constitute strong recommendations based on the highest level...
Conavi Medical Reports Fiscal Q1 2025 Interim Financial Results and Operational Highlights
03. März 2025 07:00 ET
|
Conavi Medical Corp.
– Completed first quarter as a public company and raised $10.6 mil CAD concurrent with listing – Next-generation Novasight design freeze completed on schedule, usability testing and system validation...
Conavi Medical Provides Shareholder Update and 2025 Outlook
23. Januar 2025 07:00 ET
|
Conavi Medical Corp.
- U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early 2026- Evolving medical guidelines position next-generation Novasight...
Conavi Medical and Minnetronix Medical Publish In-Depth Collaboration Review
07. Januar 2025 07:00 ET
|
Conavi Medical Corp.
TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing,...
Conavi Medical Announces Grant of Stock Options
06. Januar 2025 07:37 ET
|
Conavi Medical Corp.
TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”) announced that its board of directors (the “Board”) has approved grants of stock...
Conavi Medical Reports Fiscal 2024 Financial Results and Operational Highlights
19. Dezember 2024 07:00 ET
|
Conavi Medical Corp.
– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million...